Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

West Pharmaceutical Services stock

WST
US9553061055
864330

Price

327.46
Today +/-
+7.73
Today %
+2.51 %

West Pharmaceutical Services stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the West Pharmaceutical Services stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the West Pharmaceutical Services stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the West Pharmaceutical Services stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze West Pharmaceutical Services's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

West Pharmaceutical Services Stock Price History

DateWest Pharmaceutical Services Price
11/26/2024327.46 undefined
11/26/2024319.35 undefined
11/25/2024319.79 undefined
11/22/2024316.59 undefined
11/21/2024320.88 undefined
11/20/2024311.66 undefined
11/19/2024304.10 undefined
11/18/2024307.21 undefined
11/15/2024314.49 undefined
11/14/2024338.12 undefined
11/13/2024346.50 undefined
11/12/2024327.68 undefined
11/11/2024327.57 undefined
11/8/2024324.10 undefined
11/7/2024323.42 undefined
11/6/2024329.38 undefined
11/5/2024323.47 undefined
11/4/2024314.77 undefined
11/1/2024316.50 undefined
10/31/2024307.93 undefined
10/30/2024313.02 undefined
10/29/2024318.41 undefined

West Pharmaceutical Services Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into West Pharmaceutical Services, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by West Pharmaceutical Services from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects West Pharmaceutical Services’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of West Pharmaceutical Services. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into West Pharmaceutical Services’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing West Pharmaceutical Services’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on West Pharmaceutical Services’s growth potential.

West Pharmaceutical Services Revenue, EBIT and net profit per share

DateWest Pharmaceutical Services RevenueWest Pharmaceutical Services EBITWest Pharmaceutical Services Net Income
2028e4.78 B undefined0 undefined0 undefined
2027e3.89 B undefined0 undefined808.24 M undefined
2026e3.38 B undefined807.33 M undefined649.31 M undefined
2025e3.09 B undefined700.39 M undefined550.37 M undefined
2024e2.91 B undefined566.34 M undefined481.29 M undefined
20232.95 B undefined705.1 M undefined593.4 M undefined
20222.89 B undefined754.9 M undefined585.9 M undefined
20212.83 B undefined757.2 M undefined661.8 M undefined
20202.15 B undefined417.7 M undefined346.2 M undefined
20191.84 B undefined297.9 M undefined241.7 M undefined
20181.72 B undefined250.5 M undefined206.9 M undefined
20171.6 B undefined240 M undefined150.7 M undefined
20161.51 B undefined225.9 M undefined143.6 M undefined
20151.4 B undefined128.6 M undefined95.6 M undefined
20141.42 B undefined181.1 M undefined127.1 M undefined
20131.37 B undefined161.9 M undefined112.3 M undefined
20121.27 B undefined141.7 M undefined80.7 M undefined
20111.19 B undefined119.3 M undefined75.5 M undefined
20101.1 B undefined108.3 M undefined65.3 M undefined
20091.06 B undefined106.4 M undefined72.6 M undefined
20081.05 B undefined125.2 M undefined86 M undefined
20071.02 B undefined113 M undefined70.7 M undefined
2006913.3 M undefined105.7 M undefined67.1 M undefined
2005699.7 M undefined73.2 M undefined46.4 M undefined
2004541.6 M undefined51.8 M undefined20.2 M undefined

West Pharmaceutical Services Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.190.180.190.240.250.290.310.320.330.340.350.370.410.460.450.450.40.370.390.410.480.540.70.911.021.051.061.11.191.271.371.421.41.511.61.721.842.152.832.892.952.913.093.383.894.78
--4.214.4023.687.6612.658.074.871.862.742.964.8912.8811.17-1.31-0.66-12.03-5.825.385.1017.2312.0129.2130.6211.723.040.384.647.976.218.063.87-1.557.865.967.387.1116.6931.921.942.18-1.256.229.1515.2522.80
32.1129.6732.6331.9125.3024.9126.3024.4625.2328.4030.1732.0528.6427.5129.2030.0733.9228.7629.0828.4031.6829.0228.0428.9227.5528.7328.7228.8028.4430.5731.7331.4632.5233.2032.0231.7432.9035.7441.5839.3638.2838.7736.5033.4429.0223.63
0.060.050.060.080.060.070.080.080.080.10.110.120.120.130.130.140.130.110.110.120.150.160.20.260.280.30.30.320.340.390.430.450.460.50.510.550.610.771.181.141.1300000
161315171317204-141923272816446381-51831204667708672657580112127951431502062413466615855934815506498080
--18.7515.3813.33-23.5330.7717.65-80.00-450.00-235.7121.0517.393.70-42.86175.00-86.36533.33-97.37-600.00-460.0072.22-35.48130.0045.654.4822.86-16.28-9.7215.386.6740.0013.39-25.2050.534.9037.3316.9943.5791.04-11.501.37-18.8914.3518.0024.50-
----------------------------------------------
----------------------------------------------
62.762.96364.564.86565.263.362.163.16464.966.96666.36660.257.657.457.758.261.66567.272.472.272.673.47471.871.472.873.87575.875.475.475.876.375.875.300000
----------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The West Pharmaceutical Services Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the West Pharmaceutical Services is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                                                 
54.28.57.412.75.11.62.22.735.227.217.427.352.331.345.342.742.133.237.868.848.847.1129.491.583.1110.291.8174.3230255.3274.6203235.9337.4439.1615.5762.6894.3853.9
26.123.323.333.435.444.14441.842.841.943.357.867.969.360.464.474.653.759.566.672.372.9107.4109.5136.1128.6138.7126.4147.2175185.7179181.4200.5253.2288.2319.3385.3489507.4512
00000000000000006.57.75.73.642.22.23.1100000000000000000
22.722.323.534.736.742.844.746.433.83834.538.148.34438.343.542.134.834.341.347.656.771.197.5111.8115.7129.2147151.8162.2176.9181.5181.1199.3215.2214.5235.7321.3378.4414.8434.7
0.60.71.53.85.14.5710.81815.71213.614.816.119.720.516.219.916.917.116.825.916.726.63530.446.25381.245.858.143.336.639.139.254.364.651.6112103135.8
0.050.050.060.080.090.10.10.10.10.10.10.140.150.160.170.160.180.160.160.160.220.230.250.280.410.370.40.440.470.560.650.660.670.640.740.891.061.371.741.921.94
0.080.090.10.130.160.170.180.20.170.170.170.190.230.210.20.220.230.20.210.220.250.280.330.380.480.530.580.550.590.670.710.710.720.780.860.820.911.011.131.261.51
99.612.51114.913.915.814.114.815.917.821.921.624.122.715.720.22220.81822.226.627.729.731.733.638.248.256.259.860.960.661.382.785.891.2192.7214.7207.7204.9210
00000000000000000000000000000000000000000
0000000000000000007.87.31.41.369.766.3555055.655.15250.648.34237.623.321.720.329.830.52318.415.1
000912.312.514.217.81514.112.733.96358.951.661.266.534.930.735.539.542.489.5102.8109.2105.3114.2112.5111.5112.5114.2108.6104.6103107.7105.8107.8111.1109.9107.3108.5
6.58.412.5147.476.99.120.29.910.912.717.827.430.748.752.8131.883.483.792.768.671.55395.782.688.787.1113.8114.885.893.696.987.549.145.24352.3104.410447
0.10.110.120.160.190.20.220.240.220.210.210.260.330.320.310.350.370.390.350.370.410.420.590.640.770.80.870.860.931.011.021.011.021.071.121.081.281.421.571.71.89
0.150.160.180.240.280.30.310.340.310.30.310.40.480.480.480.510.550.550.510.530.620.650.830.921.191.171.271.291.41.561.671.671.71.721.861.982.342.793.313.623.83
                                                                                 
22224.14.14.14.14.14.24.24.24.24.24.24.34.34.34.34.34.38.68.68.68.68.68.68.68.617.217.617.818.118.418.818.818.818.818.818.818.8
5.566.110.81010.812.312.41419.32023.223.5242432.931.732.131.630.930.124.539.352.864.369.372.977.376.370.7120160.2207.8260.4309.3282272.7267.3249232.2120.2
0.090.10.110.130.130.150.160.160.140.150.170.190.210.220.250.250.280.270.250.260.280.290.330.380.450.520.570.610.660.720.810.90.961.071.181.351.551.852.462.993.52
-2.9-4.1-2-0.47.18615.411.912.21117.120.416.73.57.2-5.3-14.5-27.4-13.118.635.87.28.331.9-44-19.2-31.4-71.9-76.7-36.7-123.9-168-192-117.8-154.6-150-111.2-161.1-184.6-146.1
0000000000000000000-0.30.30.61.72.31.7-0.9-0.50.10.40.84.34.75.45.20.50.40.40.61.51.62.3
0.10.110.120.140.160.170.190.190.170.190.210.230.260.260.280.290.310.290.260.280.330.360.380.450.560.550.630.670.680.730.910.961.031.161.391.51.692.022.563.063.52
9.58.87.314.215.913.216.31816.420.414.11722.523.918.620.825.523.522.219.228.629.345.861.280.467.668.463.289.8102.9108103.1119.8122138.1130.4156.8213.1232.2215.4242.4
5.94.84.711.719.622.18.61245.229.926.847.49.713.913.417.115.715.11818.426.426.426.936.939.944.348.950.447.359.38577.981.774.186.193135.3159.2195.4159.2179
4.10.502.701.81622.4000019.824.924.432.733.228.826.434.855.950.855.358.362.143.353.355.85666.941.744.343.542.555.360.247.2128.8122.3142.2116.4
00000000000000000000000000000000000000000
4.85.44.414.69.26.3612.39.310.67.721.99.82.91.636.129.63.68.715.88100.30.50.53.90.50.350.132.72.227.269.32.400.12.32.344.22.2134
24.319.516.443.244.743.446.964.770.960.948.686.361.865.658106.71047175.388.2118.9116.5128.3156.9182.9159.1171.1169.7243.2261.8236.9252.5314.3241279.5283.7341.6503.4594.1519671.8
20.818.52629.751.348.852.166.249.131.524.635.9104.595.587.4105141.5195.8184.3159.2167150.8280.7235.8394.6382.1379.1358.1299.3378.8371.3308.3228.9226.2197196255252.9208.8206.772.8
10.21416.72122.135.225.224.814.315.518.424.434.339.730.139.1485146.848.544.835.531.943.546.620.422.92021.620.818.915.712.49.210.413.115.510.44.914.312.7
00000000000025.224.324.326.626.325.528.132.235.345.348.662.770.6120118.8120.8180.1173.7138.1136.3115.6122.89689.8156.1172.6170.6191.9191.2
3132.542.750.773.48477.39163.4474360.3164159.5141.8170.7215.8272.3259.2239.9247.1231.6361.2342511.8522.5520.8498.9501573.3528.3460.3356.9358.2303.4298.9426.6435.9384.3412.9276.7
55.35259.193.9118.1127.4124.2155.7134.3107.991.6146.6225.8225.1199.8277.4319.8343.3334.5328.1366348.1489.5498.9694.7681.6691.9668.6744.2835.1765.2712.8671.2599.2582.9582.6768.2939.3978.4931.9948.5
0.150.160.180.230.270.30.310.350.30.30.30.380.480.490.480.570.630.640.60.610.70.710.870.951.251.231.321.341.421.571.681.671.71.761.972.082.462.963.543.994.47
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of West Pharmaceutical Services provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand West Pharmaceutical Services's financial health and stability.

Assets

West Pharmaceutical Services's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that West Pharmaceutical Services must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of West Pharmaceutical Services after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into West Pharmaceutical Services's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
161315171317204-81923272816446351-5183120466770867265758011212795143150206241346661585593
810121416182022242322232930313230303131313347525660687375768590899096104103109122120137
1321010-2-301-22-5-7584118-224-67-4-12517-82141015-5-42-3037
0-2-4-4-4-10115-11-80-14220-103-8-170-20-5-14-30-15-12-21-3-3-30-10-58-41-28-14-10-193-11-20
-1-1-104011026102020-326-10181-1018172427172421643468764131194567748352
0001243554336655912131098131412151516181516161488888866
0001011712710101113121420141525-4871715252519162016343733483142474817110990
2423242830264236443438494663677162393852686893143129135137138130187220182212219263288367472584724776
-16-20-19-29-43-29-34-33-25-22-33-27-31-31-34-41-39-47-45-36-62-57-54-90-134-139-107-73-96-132-155-112-131-170-130-104-126-174-253-284-362
-17-17-19-41-41-27-39-31-24-14-25-37-100-24-33-73-54-50-20-30-56-24-227-89-155-119-121-74-120-116-149-104-129-175-133-100-228-179-253-288-368
020-1212-51178-10-6971-32-15-3245532-1730-2119-140-2316582-5-23-101-50-3-6
00000000000000000000000000000000000000000
-1-16713-3113-15-15-71249-13-1483430-5-25-3-15121-59137-9-10-14-717-5-22-27-69-34062-2-2-44-2
000410-3-1112332-64-57-15-903313114-3813126191310-26-34-38-52-86-114-194-400
-5-701115-7-7-4-19-18-10843-28-7-19811-15-33-12-15120-6084-29-22-34-24-3-5-30-41-113-109-80-36-137-168-293-459
-1-2-335000000000000000001103-2403-28781700-100-10
-3-3-3-3-4-4-5-6-6-6-7-7-8-8-9-9-10-9-10-11-11-12-14-15-17-18-20-21-23-24-26-29-32-35-39-42-45-48-51-54-57
104-15-7-3000222-9925-2114-20-8431-20-161-21-427-1870682519-7132101101176147131-40
8.23.94.5-0.5-12.7-2.98.62.818.911.6522.714.831.733.329.223.2-8.7-7.116.26.411.53953.5-4.9-4.129.964.533.955.464.770.880.849.2132.5183.9240.8298.1330.6439.4414.5
00000000000000000000000000000000000000000

West Pharmaceutical Services stock margins

The West Pharmaceutical Services margin analysis displays the gross margin, EBIT margin, as well as the profit margin of West Pharmaceutical Services. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for West Pharmaceutical Services.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the West Pharmaceutical Services's sales revenue. A higher gross margin percentage indicates that the West Pharmaceutical Services retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the West Pharmaceutical Services's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the West Pharmaceutical Services's total revenue generated. When comparing the revenue margin year over year, investors can gauge the West Pharmaceutical Services's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the West Pharmaceutical Services. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the West Pharmaceutical Services's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

West Pharmaceutical Services Margin History

West Pharmaceutical Services Gross marginWest Pharmaceutical Services Profit marginWest Pharmaceutical Services EBIT marginWest Pharmaceutical Services Profit margin
2028e38.28 %0 %0 %
2027e38.28 %0 %20.77 %
2026e38.28 %23.91 %19.23 %
2025e38.28 %22.64 %17.79 %
2024e38.28 %19.45 %16.53 %
202338.28 %23.9 %20.12 %
202239.36 %26.15 %20.3 %
202141.59 %26.74 %23.37 %
202035.76 %19.46 %16.13 %
201932.92 %16.19 %13.14 %
201831.76 %14.59 %12.05 %
201732.06 %15.01 %9.42 %
201633.21 %14.97 %9.52 %
201532.56 %9.19 %6.83 %
201431.5 %12.74 %8.94 %
201331.77 %11.83 %8.21 %
201230.61 %11.19 %6.37 %
201128.46 %10.01 %6.33 %
201028.8 %9.8 %5.91 %
200928.76 %10.08 %6.88 %
200828.79 %11.91 %8.18 %
200727.61 %11.08 %6.93 %
200628.99 %11.57 %7.35 %
200528.08 %10.46 %6.63 %
200429.01 %9.56 %3.73 %

West Pharmaceutical Services Stock Sales Revenue, EBIT, Earnings per Share

The West Pharmaceutical Services earnings per share therefore indicates how much revenue West Pharmaceutical Services has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue West Pharmaceutical Services earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates West Pharmaceutical Services's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of West Pharmaceutical Services’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating West Pharmaceutical Services's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

West Pharmaceutical Services Revenue, EBIT and net profit per share

DateWest Pharmaceutical Services Sales per ShareWest Pharmaceutical Services EBIT per shareWest Pharmaceutical Services Earnings per Share
2028e65.98 undefined0 undefined0 undefined
2027e53.73 undefined0 undefined11.16 undefined
2026e46.62 undefined0 undefined8.97 undefined
2025e42.71 undefined0 undefined7.6 undefined
2024e40.21 undefined0 undefined6.65 undefined
202339.17 undefined9.36 undefined7.88 undefined
202238.09 undefined9.96 undefined7.73 undefined
202137.11 undefined9.92 undefined8.67 undefined
202028.32 undefined5.51 undefined4.57 undefined
201924.4 undefined3.95 undefined3.21 undefined
201822.78 undefined3.32 undefined2.74 undefined
201721.1 undefined3.17 undefined1.99 undefined
201620.12 undefined3.01 undefined1.91 undefined
201518.97 undefined1.74 undefined1.3 undefined
201419.52 undefined2.49 undefined1.75 undefined
201319.17 undefined2.27 undefined1.57 undefined
201217.64 undefined1.97 undefined1.12 undefined
201116.11 undefined1.61 undefined1.02 undefined
201015.05 undefined1.48 undefined0.89 undefined
200914.54 undefined1.47 undefined1 undefined
200814.56 undefined1.73 undefined1.19 undefined
200714.09 undefined1.56 undefined0.98 undefined
200613.59 undefined1.57 undefined1 undefined
200510.76 undefined1.13 undefined0.71 undefined
20048.79 undefined0.84 undefined0.33 undefined

West Pharmaceutical Services business model

West Pharmaceutical Services Inc. is a leading company in the development and manufacturing of innovative solutions for drug delivery and medical devices. The company has been in the market for over 100 years and is headquartered in Exton, Pennsylvania, USA. West operates in more than 50 countries worldwide and employs over 9,000 employees. The history of West Pharmaceutical Services begins in 1923, when Herman O. West founded the company in Philadelphia. Initially, West primarily produced rubber seals for canning jars and bottle closures. In the 1930s, West entered the production of plastic parts used in products such as tube radios. In the mid-1950s, West began to venture into the production of medical devices and accessories, such as syringe stoppers. Since then, the company has continuously expanded its product range and is now a leading provider of pharmaceutical delivery solutions. West is divided into three business segments: Healthcare Delivery Systems (HDS), Pharmaceutical Packaging Systems (PPS), and Contract Manufacturing Organization (CMO). The Healthcare Delivery Systems (HDS) segment specializes in the development and manufacturing of devices and systems for drug delivery. This includes syringes, injection devices, pen systems, nasal and inhalation devices. These products are developed in collaboration with various pharmaceutical companies to simplify and improve medication delivery. West has also developed many patented products, such as the "SmartDose" system, which enables accurate dosage delivery. The Pharmaceutical Packaging Systems (PPS) segment offers packaging solutions for pharmaceuticals. This includes injection vials, caps, and closures made of glass or plastic. PPS has also developed specialized packaging solutions, such as the "Ready Pack" solution, which packages sterile products in a safe and user-friendly environment. Another example is the "Westar UD" system, which allows for accurate and safe dosing of medications in ampoules. The Contract Manufacturing Organization (CMO) segment offers customized services, including design and development of packaging solutions and manufacturing of pharmaceuticals and medical devices. CMO manufacturing services include development, manufacturing, filling, and packaging of sterility products. West has a wide customer base in the pharmaceutical and biotech industry. The company works closely with its customers to develop customized solutions that meet their specific needs. West also has strong partnerships with other leading companies in the industry, such as Merck or Daikyo. Overall, West Pharmaceutical Services is distinguished by its high focus on quality and safety. The company places great emphasis on compliance with regulatory requirements and the use of safety-conscious manufacturing technologies. West also has its own quality control department, which ensures the high quality of its products and satisfies its customers. In summary, West Pharmaceutical Services is a leading provider of pharmaceutical delivery solutions and packaging solutions. With a wide portfolio of innovative products and services tailored to meet customer needs, West can provide safe and effective solutions to its customers worldwide. West Pharmaceutical Services is one of the most popular companies on Eulerpool.com.

West Pharmaceutical Services SWOT Analysis

Strengths

1. Established Market Presence: West Pharmaceutical Services Inc has a strong foothold in the global pharmaceutical packaging market, backed by its long history and reputation.

2. Innovative Product Portfolio: The company offers a wide range of innovative packaging solutions and drug delivery systems that cater to the evolving needs of the pharmaceutical industry.

3. Strong Customer Relationships: West Pharmaceutical Services Inc has built solid relationships with its global customer base, which includes leading pharmaceutical companies, allowing for long-term partnerships and repeat business.

Weaknesses

1. Dependency on Pharmaceutical Industry: The company's business is heavily reliant on the demand and performance of the pharmaceutical industry, exposing it to potential economic downturns or regulatory changes.

2. Limited Presence in Emerging Markets: West Pharmaceutical Services Inc has limited market penetration in emerging economies, which restricts its growth opportunities in regions with high pharmaceutical market potential.

3. Vulnerability to Supply Chain Disruptions: Any disruptions in the supply chain, such as raw material shortages or logistics challenges, could negatively impact the company's production and delivery capabilities.

Opportunities

1. Growing Pharmaceutical Market: The global pharmaceutical market is expanding, driven by increased healthcare spending and the demand for advanced drug delivery systems. West Pharmaceutical Services Inc can capitalize on this growth by continuously innovating and offering new solutions.

2. Expansion into Emerging Markets: Developing a stronger presence in emerging economies, particularly in Asia and Latin America, could provide West Pharmaceutical Services Inc with access to new customers and untapped market potential.

3. Mergers and Acquisitions: Strategic acquisitions or partnerships can enable the company to expand its product portfolio and enter new market segments, enhancing its competitive position.

Threats

1. Intense Competition: West Pharmaceutical Services Inc faces fierce competition from other established pharmaceutical packaging companies, as well as emerging players, which could negatively impact its market share and profitability.

2. Regulatory and Compliance Risks: The company operates in a highly regulated industry, and non-compliance with quality standards or changing regulations can result in legal issues or product recalls.

3. Technological Advancements: Rapid technological advancements in the pharmaceutical packaging sector may require significant investments to stay ahead, posing challenges for West Pharmaceutical Services Inc to keep up with evolving customer demands.

West Pharmaceutical Services Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

West Pharmaceutical Services Revenue by Segment

Segmente20192018201720162015201420132012
Contract Manufacturing----302.6 M USD297.1 M USD281.4 M USD275.1 M USD
Proprietary Products----97.6 M USD105.4 M USD92.7 M USD77 M USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

West Pharmaceutical Services Revenue by Segment

Segmente20192018201720162015201420132012
Proprietary Products1.4 B USD1.31 B USD------
Contract Manufactured Products441.5 M USD409.1 M USD------

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

West Pharmaceutical Services Revenue by Segment

Segmente20192018201720162015201420132012
Packaging Systems----1 B USD1.02 B USD996 M USD915.1 M USD
Proprietary Products--1.24 B USD1.19 B USD----
Delivery Systems----400.2 M USD402.5 M USD281.4 M USD275.1 M USD
Contract-Manufactured Products--362.5 M USD-----
Contract Manufacturing---320.2 M USD----
Corporate and Eliminations---300,000 USD-1 M USD-1.1 M USD-800,000 USD-1.7 M USD-800,000 USD
Intersegment Elimination-200,000 USD-300,000 USD-300,000 USD-1 M USD-1.1 M USD-800,000 USD-1.7 M USD-800,000 USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

West Pharmaceutical Services Revenue by Segment

Segmente20192018201720162015201420132012
Corporate and Eliminations-200,000 USD-300,000 USD------

West Pharmaceutical Services Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

West Pharmaceutical Services Revenue by Segment

DateFranceGermanyIrelandIRELANDOther CountriesOther European countriesOther European CountriesUnited States
2023282.9 M USD406.1 M USD285.7 M USD-348.5 M USD388.1 M USD-1.24 B USD
2021213 M USD474.3 M USD247.6 M USD-357.4 M USD341.3 M USD-1.2 B USD
2019150.6 M USD236.3 M USD-173.8 M USD213.4 M USD251.1 M USD-814.7 M USD
2018127.5 M USD235.9 M USD--201.8 M USD386.1 M USD-766.1 M USD
2017125.6 M USD226.4 M USD--194 M USD318.5 M USD-734.6 M USD
2016116.3 M USD200.6 M USD--185.6 M USD-268.3 M USD738.3 M USD
2015107.6 M USD194 M USD--178.8 M USD-252 M USD667.4 M USD
2014118.2 M USD219.4 M USD--143.3 M USD-285 M USD655.5 M USD
2013112.6 M USD219.6 M USD--142.3 M USD-279.4 M USD614.5 M USD
2012102.6 M USD184.4 M USD--135.2 M USD251.4 M USD-592.8 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

West Pharmaceutical Services Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

West Pharmaceutical Services historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

West Pharmaceutical Services shares outstanding

The number of shares was West Pharmaceutical Services in 2023 — This indicates how many shares 75.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue West Pharmaceutical Services earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates West Pharmaceutical Services's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of West Pharmaceutical Services’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating West Pharmaceutical Services's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

West Pharmaceutical Services stock splits

In West Pharmaceutical Services's history, there have been no stock splits.

West Pharmaceutical Services dividend history and estimates

In 2023, West Pharmaceutical Services paid a dividend amounting to 0.77 USD. Dividend means that West Pharmaceutical Services distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for West Pharmaceutical Services provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify West Pharmaceutical Services’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating West Pharmaceutical Services's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

West Pharmaceutical Services Dividend History

DateWest Pharmaceutical Services Dividend
2028e0.92 undefined
2027e0.92 undefined
2026e0.92 undefined
2025e0.92 undefined
2024e0.92 undefined
20230.77 undefined
20220.73 undefined
20210.69 undefined
20200.65 undefined
20190.61 undefined
20180.57 undefined
20170.53 undefined
20160.49 undefined
20150.45 undefined
20140.62 undefined
20130.39 undefined
20120.37 undefined
20110.35 undefined
20100.33 undefined
20090.31 undefined
20080.29 undefined
20070.27 undefined
20060.25 undefined
20050.23 undefined
20040.21 undefined

West Pharmaceutical Services dividend payout ratio

In 2023, West Pharmaceutical Services had a payout ratio of 10.55%. The payout ratio indicates the percentage of the company's profits that West Pharmaceutical Services distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for West Pharmaceutical Services represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for West Pharmaceutical Services could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate West Pharmaceutical Services's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

West Pharmaceutical Services Payout Ratio History

DateWest Pharmaceutical Services Payout ratio
2028e9.77 %
2027e9.66 %
2026e9.88 %
2025e9.78 %
2024e9.32 %
202310.55 %
20229.46 %
20217.97 %
202014.22 %
201919 %
201820.8 %
201726.77 %
201625.65 %
201534.62 %
201435.43 %
201324.52 %
201232.59 %
201133.82 %
201036.93 %
200930.5 %
200823.95 %
200727.32 %
200624.75 %
200531.69 %
200466.41 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for West Pharmaceutical Services.

West Pharmaceutical Services latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.52 1.85  (22.11 %)2024 Q3
6/30/20241.76 1.52  (-13.56 %)2024 Q2
3/31/20241.29 1.56  (21.26 %)2024 Q1
12/31/20231.8 1.83  (1.93 %)2023 Q4
9/30/20231.87 2.16  (15.21 %)2023 Q3
6/30/20231.95 2.11  (8.46 %)2023 Q2
3/31/20231.69 1.98  (17.48 %)2023 Q1
12/31/20221.39 1.77  (27.34 %)2022 Q4
9/30/20222.14 2.03  (-5.19 %)2022 Q3
6/30/20222.24 2.47  (10.49 %)2022 Q2
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the West Pharmaceutical Services stock

Eulerpool World ESG Rating (EESG©)

86/ 100

🌱 Environment

69

👫 Social

99

🏛️ Governance

90

Environment

Scope 1 - Direct Emissions
31,371
Scope 2 - Indirect emissions from purchased energy
91,563
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
122,934
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees36
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

West Pharmaceutical Services shareholders

%
Name
Stocks
Change
Date
12.30683 % The Vanguard Group, Inc.8,912,6054,6516/30/2024
5.78981 % BlackRock Institutional Trust Company, N.A.4,192,977-37,8596/30/2024
4.42473 % State Street Global Advisors (US)3,204,388-14,5926/30/2024
3.44089 % Artisan Partners Limited Partnership2,491,892425,3556/30/2024
3.36532 % Franklin Advisers, Inc.2,437,163-7,8116/30/2024
3.30575 % Walter Scott & Partners Ltd.2,394,0211,7866/30/2024
3.22154 % APG Asset Management N.V.2,333,037-4,6616/30/2024
3.07818 % AllianceBernstein L.P.2,229,2151,602,2936/30/2024
2.42667 % Brown Advisory1,757,395119,5186/30/2024
2.38516 % Geode Capital Management, L.L.C.1,727,3339,9376/30/2024
1
2
3
4
5
...
10

West Pharmaceutical Services Executives and Management Board

Mr. Eric Green

(53)
West Pharmaceutical Services Chairman of the Board, President, Chief Executive Officer (since 2015)
Compensation 7.92 M

Mr. Bernard Birkett

(54)
West Pharmaceutical Services Chief Financial and Operations Officer, Senior Vice President
Compensation 3.01 M

Ms. Kimberly Mackay

(57)
West Pharmaceutical Services Senior Vice President, General Counsel, Corporate Secretary
Compensation 1.45 M

Mr. Silji Abraham

(51)
West Pharmaceutical Services Senior Vice President, Chief Technology Officer
Compensation 1.31 M

Ms. Cindy Reiss-Clark

(49)
West Pharmaceutical Services Senior Vice President - Global Markets and Commercial Solutions, Chief Commercial Officer
Compensation 1.23 M
1
2
3
4

West Pharmaceutical Services Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Rimoni Industries Ltd. Stock
Rimoni Industries Ltd.
SupplierCustomer0,500,730,740,670,810,82
scPharmaceuticals Inc. Stock
scPharmaceuticals Inc.
SupplierCustomer0,150,47-0,30-0,43-0,53-0,18
1

Most common questions regarding West Pharmaceutical Services

What values and corporate philosophy does West Pharmaceutical Services represent?

West Pharmaceutical Services Inc represents a commitment to quality, innovation, and patient safety. As a global leader in pharmaceutical packaging and delivery systems, the company focuses on providing solutions that ensure the integrity and efficacy of drug products. With a corporate philosophy centered on collaboration, West strives to enable its customers' success by understanding their needs and delivering reliable, advanced technologies. By consistently putting patient well-being at the forefront, West aims to enhance the global healthcare landscape through its cutting-edge products and services.

In which countries and regions is West Pharmaceutical Services primarily present?

West Pharmaceutical Services Inc is primarily present in various countries and regions around the world. The company has a strong global presence and operates in multiple key markets. Some of the prominent countries and regions where West Pharmaceutical Services Inc has a significant presence include the United States, Europe, Asia-Pacific, and Latin America. Its commitment to delivering innovative solutions and high-quality products has helped establish a strong foothold in these markets. With its global reach, West Pharmaceutical Services Inc continues to expand its operations and serve customers across different regions.

What significant milestones has the company West Pharmaceutical Services achieved?

West Pharmaceutical Services Inc has achieved several significant milestones. It has become a global leader in innovative solutions for injectable drug administration, serving pharmaceutical, biotechnology, and healthcare industries. The company has successfully expanded its global footprint, establishing manufacturing facilities and expanding operations in various regions. It has consistently focused on research and development, resulting in the introduction of cutting-edge technologies and advanced products. West Pharmaceutical Services Inc has also prioritized sustainability initiatives, promoting eco-friendly practices and reducing its environmental impact. Overall, the company's dedication to excellence, global expansion, technological advancements, and environmental consciousness have been key milestones in its success.

What is the history and background of the company West Pharmaceutical Services?

West Pharmaceutical Services Inc, founded in 1923, is a global leader in innovative solutions for injectable drug administration. With a rich history spanning nearly a century, the company has continuously evolved to meet the needs of the healthcare industry. West specializes in designing and manufacturing packaging and delivery systems for pharmaceuticals, such as vials, syringe components, and auto-injectors. Their cutting-edge technologies ensure drug containment, administration, and patient safety. Recognized for excellence in quality and reliability, West serves pharmaceutical, biotechnology, and generics companies worldwide. With a commitment to advancing healthcare, West Pharmaceutical Services Inc is at the forefront of enabling the safe and efficient delivery of life-saving medications.

Who are the main competitors of West Pharmaceutical Services in the market?

The main competitors of West Pharmaceutical Services Inc in the market are Becton, Dickinson and Company (BD), Catalent Inc, and Gerresheimer AG.

In which industries is West Pharmaceutical Services primarily active?

West Pharmaceutical Services Inc is primarily active in the pharmaceutical and healthcare industries.

What is the business model of West Pharmaceutical Services?

The business model of West Pharmaceutical Services Inc. revolves around the manufacturing and distribution of innovative packaging and delivery solutions for the pharmaceutical and healthcare industries. West Pharmaceutical specializes in the development and production of advanced systems, such as drug delivery systems, injectable components, and analytical lab services. With a strong focus on quality, safety, and patient outcomes, West Pharmaceutical collaborates with pharmaceutical companies worldwide to provide customized packaging solutions that enhance the stability, efficacy, and convenience of drug delivery. By leveraging their expertise in materials science, engineering, and technology, West Pharmaceutical Services Inc. positions itself as a trusted partner in supporting the global healthcare industry.

What is the P/E ratio of West Pharmaceutical Services 2024?

The West Pharmaceutical Services P/E ratio is 51.23.

What is the P/S ratio of West Pharmaceutical Services 2024?

The West Pharmaceutical Services P/S ratio is 8.47.

What is the Quality Investing of West Pharmaceutical Services?

The Quality Investing for West Pharmaceutical Services is 9/10.

What is the revenue of West Pharmaceutical Services 2024?

The expected West Pharmaceutical Services revenue is 2.91 B USD.

How high is the profit of West Pharmaceutical Services 2024?

The expected West Pharmaceutical Services profit is 481.29 M USD.

What is the business model of West Pharmaceutical Services

West Pharmaceutical Services Inc. is a leading provider of innovative packaging and delivery systems for the pharmaceutical, biotechnology, and medical industries. The company was founded in 1923 and is headquartered in Exton, Pennsylvania, USA. The business model of West Pharmaceutical Services Inc. is based on three main divisions: Primary Packaging, Drug Delivery Systems, and Healthcare Analytics. In each of these divisions, the company offers various products and services to meet the needs of its customers. Primary Packaging In the Primary Packaging division, West Pharmaceutical Services offers various products used for the packaging of drugs. These include stoppers, vials, caps, closures, and various other components. West Pharmaceutical Services specializes in innovative packaging solutions that help increase the safety and efficacy of medications. This includes special coatings that enhance the barrier properties of the packaging and reduce the ingress of oxygen and moisture. Drug Delivery Systems The Drug Delivery Systems division includes a wide range of products used for the administration of medications. These include syringes, pens, auto-injectors, nasal sprays, powder inhalers, and various other systems. West Pharmaceutical Services develops innovative solutions that contribute to the safe and uncomplicated administration of medications. The focus is on improving patient safety. Healthcare Analytics In the Healthcare Analytics division, West Pharmaceutical Services uses modern technologies to collect and analyze health data. The aim is to fill information gaps and enable better decision-making in healthcare. The data analysis and visualization provided by West Pharmaceutical Services help healthcare providers identify trends, make predictions, and improve treatment outcomes. Summary West Pharmaceutical Services offers innovative packaging and delivery systems for the pharmaceutical, biotechnology, and medical industries. It serves three main divisions: Primary Packaging, Drug Delivery Systems, and Healthcare Analytics. The company strives to improve the safety and efficacy of medications and enhance patient safety. Through the analysis of health data, the company contributes to making the healthcare system more efficient and cost-effective.

What is the West Pharmaceutical Services dividend?

West Pharmaceutical Services pays a dividend of 0.73 USD distributed over 4 payouts per year.

How often does West Pharmaceutical Services pay dividends?

West Pharmaceutical Services pays out a dividend 4 times a year.

What is the West Pharmaceutical Services ISIN?

The ISIN of West Pharmaceutical Services is US9553061055.

What is the West Pharmaceutical Services WKN?

The WKN of West Pharmaceutical Services is 864330.

What is the West Pharmaceutical Services ticker?

The ticker of West Pharmaceutical Services is WST.

How much dividend does West Pharmaceutical Services pay?

Over the past 12 months, West Pharmaceutical Services paid a dividend of 0.77 USD . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, West Pharmaceutical Services is expected to pay a dividend of 0.92 USD.

What is the dividend yield of West Pharmaceutical Services?

The current dividend yield of West Pharmaceutical Services is 0.24 %.

When does West Pharmaceutical Services pay dividends?

West Pharmaceutical Services pays a quarterly dividend. This is distributed in the months of February, May, August, December.

How secure is the dividend of West Pharmaceutical Services?

West Pharmaceutical Services paid dividends every year for the past 53 years.

What is the dividend of West Pharmaceutical Services?

For the upcoming 12 months, dividends amounting to 0.92 USD are expected. This corresponds to a dividend yield of 0.29 %.

In which sector is West Pharmaceutical Services located?

West Pharmaceutical Services is assigned to the 'Health' sector.

Wann musste ich die Aktien von West Pharmaceutical Services kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of West Pharmaceutical Services from 11/20/2024 amounting to 0.21 USD, you needed to have the stock in your portfolio before the ex-date on 11/13/2024.

When did West Pharmaceutical Services pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of West Pharmaceutical Services in the year 2023?

In the year 2023, West Pharmaceutical Services distributed 0.73 USD as dividends.

In which currency does West Pharmaceutical Services pay out the dividend?

The dividends of West Pharmaceutical Services are distributed in USD.

All fundamentals about West Pharmaceutical Services

Our stock analysis for West Pharmaceutical Services Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of West Pharmaceutical Services Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.